MTOR and melanoma: Apigenin has been shown to activate the cleaved caspase-3 and PARP expression sites, down-regulate the Twist1, p-mTOR, ERK1/2 proteins, deactivate FAK/ERK1/2 pathways and halt the phosphorylation of STAT3 in different melanoma cases [131,132] (Figure 5).